Biomarkers for alzheimer’s disease in the current state: a narrative review

HIGHLIGHTS

• who: Serafettin Gunes and colleagues from the Program in Health Data Science, Faculty of Medicine, University of Porto, Porto, Portugal have published the paper: Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review, in the Journal: (JOURNAL)
• what: The study showed that AD findings were observed in 77.4% of all AD patients using MRI, 81.6% using SPECT, 93.1% using fluorodeoxyglucose (FDG) PET, and 94.0% using CSF biomarkers. This study showed that salivary metabolite markers could discriminate between AD, presymptomatic (PP), and MCI patients; AD and PP patients were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.